Total (N = 17) | |
---|---|
Age (years), median (IQR) | 46.0 (43.0–48.0) |
Parity, median (IQR) | 1.0 (0.0–2.0) |
BMI (kg/m2), median (IQR) | 22.0 (20.5–26.2) |
Menorrhagia, n (%) | 17 (100) |
Dysmenorrhea, n (%) | 4 (24) |
Hemoglobin (g/dL), median (IQR) | 10.2 (7.9–10.6) |
Diameter of leiomyomaa (mm), median (IQR) | 39.0 (28.0–54.0) |
Volume of leiomyomaa,b (cm3), median (IQR) | 30.1 (10.8–55.9) |
Leiomyoma protrusion ratea,c (%), median (IQR) | 62.0 (49.0–69.0) |
FIGO type of submucosal leiomyomaa, n (%) | |
Type 0 | 2 (12) |
Type 1 | 11 (65) |
Type 2 | 4 (24) |
Treatment periods (days), median (IQR) | 126.0 (84.0–170.0) |